コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 levels of CYP27B1 compared with homeostatic myeloid cells.
2 the host response to cytosolic viral RNA in myeloid cells.
3 g and proinflammatory cytokine production in myeloid cells.
4 direct interaction of activated T cells and myeloid cells.
5 mors, but is undermined by immunosuppressive myeloid cells.
6 t liver macrophages and infiltrating Gr-1(+) myeloid cells.
7 expression patterns resembling inflammatory myeloid cells.
8 ails broad pro-inflammatory gene programs in myeloid cells.
9 ability, and increased brain infiltration by myeloid cells.
10 ch, in turn, regulated these key outcomes in myeloid cells.
11 ses have been characterized, particularly in myeloid cells.
12 ng this technology, we deleted IRF5 in human myeloid cells.
13 igh degree of heterogeneity among human lung myeloid cells.
14 jury of newly recruited peripherally-derived myeloid cells.
15 aining the phagocytic ability of homeostatic myeloid cells.
16 yte immunoglobulin-like receptors (LILRs) on myeloid cells.
17 R1 and its roles influencing the function of myeloid cells.
18 ressions of alpha7nAChR in differential lung myeloid cells.
19 expression systems and Traf3ip3(-/-) primary myeloid cells.
20 ognition receptor (PRR)-induced cytokines in myeloid cells.
21 mia by invading and replicating in mammalian myeloid cells.
22 self-renewal, and proliferation of immature myeloid cells.
23 ppressive function of bone marrow Ly6C(high) myeloid cells.
24 ion of VDR in intestinal epithelial cells or myeloid cells.
25 amine the role of IL-33 and ST2 signaling in myeloid cells.
26 ccompanied by an infiltration of T cells and myeloid cells.
28 n amplifier triggering receptor expressed on myeloid cells-1 (TREM-1) and its putative ligand the neu
29 ils through triggering receptor expressed on myeloid cells-1 (TREM-1) and the ICAM-1(+) neutrophils i
30 and soluble triggering receptor expressed on myeloid cells 2 (sTREM2), as well as a marker of neurona
31 variants of triggering receptor expressed on myeloid cells 2 (TREM2) are linked with an enhanced risk
32 a-expressed triggering receptor expressed on myeloid cells 2 (TREM2) gene increase AD risk 2- to 4-fo
34 Mutation of Triggering receptor expressed on myeloid cells 2 (TREM2) impairs the response of microgli
35 ia receptor triggering receptor expressed on myeloid cells 2 (TREM2) increase AD risk, and activation
36 iant of the Triggering-Receptor-Expressed on Myeloid cells 2 (TREM2) increases the risk of Alzheimer'
37 ed stimulation of the triggering receptor of myeloid cells 2 (TREM2) is on the forefront of these can
38 Microglial triggering receptor expressed on myeloid cells 2 (TREM2) signaling plays pivotal roles in
41 sing TREM2 (triggering receptor expressed on myeloid cells 2) and displaying a fibrosis-promoting phe
42 A member 1, triggering receptor expressed on myeloid cells 2, CD163; P < 0.05-0.0001), endosomal proc
43 we showed that circulating pro-inflammatory myeloid cells accumulated in atherosclerotic plaques and
44 x found upregulated gene pathways related to myeloid cell activation, myeloid cell migration, and pha
47 racterized the phenotypes of CP-infiltrating myeloid cells after transient middle cerebral artery occ
49 re we show in mice that loss of C9orf72 from myeloid cells alone is sufficient to recapitulate the ag
50 ulate unifying inflammatory features in both myeloid cells and adipocytes and hint at an underappreci
51 alveolar epithelium to metabolically process myeloid cells and advance antibacterial inflammation.
52 rotein and TREM2-regulated function in human myeloid cells and are the first to show a role for MEK1/
53 erized by the excessive production of mature myeloid cells and arise from the acquisition of somatic
54 rgans in vivo and implicate tumor-associated myeloid cells and associated signals as potential therap
55 s is associated with inflammatory changes of myeloid cells and atherosclerosis, but the underlying me
59 (SLE), these antibodies bind Fc receptors on myeloid cells and induce proinflammatory cytokine produc
61 ore efficient bacterial killing by Ly6B.2(+) myeloid cells and macrophages compared to WT neonates.
62 rive the generation of Tregs and tolerogenic myeloid cells and PD-1 up-regulation in CD8(+) T cells.
63 ed bacterial-induced cytokines in intestinal myeloid cells and PRR-enhanced antimicrobial pathways in
64 ditional ablation of EP2 receptors in immune myeloid cells and show that systemic EP2 antagonism bloc
65 in the tumor microenvironment (TME) in which myeloid cells and T cells were the most abundant stromal
66 nctions by dampening the interaction between myeloid cells and T cells, orthogonal to PD-1 and other
68 ly expressed in circulating and intratumoral myeloid cells and that high IL8 expression is associated
69 onse matrix that can infer representation of myeloid cells and the cytokine environment they encounte
70 x interactions between resident lymphoid and myeloid cells and their communications with the surround
71 eloid cells to cocultures of LACC1-deficient myeloid cells and wild-type CD4(+) T cells restored T-ce
72 tinal microbiota, diminished infiltration by myeloid cells, and an accumulation of intraluminal polya
73 osomal pathway is diminished in C9orf72(-/-) myeloid cells, and blocking STING suppresses hyperactive
74 i-tumor immunity through effects on T cells, myeloid cells, and other cell types within the tumor mic
75 ly augment T cell responses in parallel with myeloid cell- and microbiome-targeted approaches that ma
82 identifies Hyal2-expressing tumor-associated myeloid cells as key players in the accumulation of LMW-
83 ideography to reveal the dynamic behavior of myeloid cells as they interact, extravasate and survey t
84 n significantly decreased brain-infiltrating myeloid cells as well as attenuated cachexia during PDAC
85 of HA-degrading activity of Hyal2-expressing myeloid cells, as the engagement of CD44 receptor with s
86 Unexpectedly, mice without Asxl2 only in myeloid cells (Asxl2DeltaLysM) were completely resistant
88 cation; GAd with the pan-EC-targeting ligand myeloid cell-binding peptide (MBP) incorporated in the c
89 ovides a significant advance in the study of myeloid cell biology, thus enabling pathway discovery an
90 cells (CNS-myeloids) and bone-marrow-derived myeloid cells (BMDMs) cooperatively regulate brain immun
91 follows: (1) CH was consistently present in myeloid cells but varied in penetrance in B and T cells;
93 isoform is activated by Gi-coupled GPCRs in myeloid cells, but the extent to which the two endogenou
94 equences, viral replication was inhibited in myeloid cells by harnessing the RNA interference pathway
95 with zirconium-89 and fluorophores to detect myeloid cells by in vivo positron emission tomography im
97 that deficiency of angiogenin (Ang) in mouse myeloid cells caused impairment of epithelial barrier in
98 id cells leading to the expansion of certain myeloid cell clones and induces changes in myeloid cell
101 monocyte/macrophages, neutrophils, and fetal myeloid cells contained viral RNA and infectious virus,
102 was required for airway inflammation, ST2(+) myeloid cells contributed to exacerbation of airway infl
103 ite adipose tissue inflammation, in part via myeloid cell contribution, is central to obesity pathoge
104 he downregulation of key pathways regulating myeloid cell cycle, maturation and regenerative function
106 l or smooth muscle cells or cardiomyocyte or myeloid cell deficiency of IDO and challenged with acute
107 endent on monocyte recruitment, as mice with myeloid cells deficient in the adhesion molecule integri
109 Importantly, mice with IRF5 deleted from myeloid cells demonstrated T cell outcomes similar to th
110 role of the histone deacetylase Hdac3 within myeloid cells demonstrated that Hdac3 promotes M2 activa
116 RNA) that plays a pivotal role in regulating myeloid cell development via targeting HOXA1 gene expres
117 capture three distinct biological processes: myeloid cell differentiation, protein phosphorylation an
119 Mice lacking AnxA1 in all cells or only in myeloid cells displayed a defect in this reparative proc
120 While the magnitude and the phenotypes of myeloid cells diverged between tMCAO and TLR2 stimulatio
121 These results reveal mechanisms whereby myeloid cells drive human cancer progression by thwartin
123 ith myocardial infarction, we observed rapid myeloid cell egress from the spleen and bone marrow by i
124 mobilizes immune-suppressive and angiogenic myeloid cells, emerging studies reveal that IL-17 can di
125 tion or growth inhibition and a reduction in myeloid cells endogenously expressing high levels of PD-
126 aNKs reduced levels of macrophages and other myeloid cells endogenously expressing high PD-L1 in peri
127 rrow responds to stress signals by expanding myeloid cells endowed with immunosuppressive functions,
128 f m(6)A methyltransferase subunit METTL14 in myeloid cells exacerbates macrophage responses to acute
129 expressing lower levels of Mcl and Mincle on myeloid cells exhibited a drastic reduction in EAE incid
131 SCs), a heterogeneous population of immature myeloid cells, expand during chronic viral (HCV, HIV) in
132 s, such as extracellular vesicle release and myeloid cell expansion, in the establishment of pre-meta
133 h was downregulated in both human and murine myeloid cells exposed to LPS as well as other TLR ligand
137 ffects of this molecule on the regulation of myeloid cells expressing RM CD200R, mimicking interactio
139 ippocampus with macrophages and inflammatory myeloid cells from the periphery, along with elevated fr
140 more often associated with innate immune and myeloid cell function pathways, whereas AA-dominant path
141 patient, we also evaluated the alteration of myeloid cell functional activity.RESULTSWe provide evide
142 ssue and fibroblasts suggests involvement in myeloid cell functions during periodontal inflammation.
143 n myeloid cell clones and induces changes in myeloid cell functions that promote atherosclerosis via
145 , whereas mutation of REVERBalpha in club or myeloid cells had no effect on the bleomycin phenotype.
146 hat soluble triggering receptor expressed on myeloid cells had the best prognostic accuracy for 30-da
147 production of calcitriol in proinflammatory myeloid cells has the potential to reduce the risk for a
148 Trained immunity, a functional state of myeloid cells, has been proposed as a compelling immune-
150 Trx1 system is dispensable for steady-state myeloid-cell hematopoiesis due to their capacity to tap
151 n lymphoid organ formation, in COPD.Methods: Myeloid cell heterogeneity and phenotype were studied in
152 Genetic deletion of the HIF-2alpha gene in myeloid cells (HIF-2alpha(mye/-) ) markedly exacerbated
153 t time to our knowledge, a novel mediator of myeloid cell-IEC crosstalk in maintaining epithelial bar
160 ation, we can delineate biological roles for myeloid cells in different cytokine environments during
161 ells, which has implications for the role of myeloid cells in disease and the utilization of these ce
172 ocytes, suggest that the sustained influx of myeloid cells in the lungs of juvenile mice during acute
173 these data suggest that monocyte/macrophage myeloid cells in the placenta play a significant role in
176 ith target immune cells and to accumulate in myeloid cells in tumours and systemic compartments.
177 ate immune cells, including ILC2s and ST2(+) myeloid cells, in RSV infection-triggered pathophysiolog
180 mice inoculated with control ZIKV.IMPORTANCE Myeloid cells, including monocytes, play a crucial role
185 ST2 deficiency in mice leads to reduced lung myeloid cell infiltration, abnormal alternatively activa
189 or the roles of PML-RARalpha in transforming myeloid cells into leukemia cells, but further uncover a
193 recent study by Strauss et al. describes how myeloid cell-intrinsic PD1 signaling limits myelopoiesis
196 e MS lesions and that activation of STAT3 in myeloid cells is essential for leukocyte infiltration, n
198 iscuss how ageing affects the development of myeloid cells leading to the expansion of certain myeloi
202 correlated with increased expression of the myeloid cell lineage-specific transcription factor IRF8
206 ing in supporting remyelination by promoting myeloid cell-mediated inflammatory responses via TNF-alp
208 in-3 and key adhesome members PXN/LPXN limit myeloid cell motility and phagocytosis, thereby providin
209 ly, we focus on pathways that raise systemic myeloid cell numbers and modulate immune cell phenotypes
210 ysregulated immune responses involving T and myeloid cells occur in COVID-19 patients with severe cli
211 a lack of type I IFNs, reduced HLA-DR in the myeloid cells of patients with severe COVID-19, and tran
214 e immunity, induced via modulation of mature myeloid cells or their bone marrow progenitors, mediates
217 f evidence suggests that bone marrow-derived myeloid cells play a critical role in the pathophysiolog
220 T cell engager leads to changes in the host myeloid cell population, both of which contribute to tre
221 on, specifically reducing cytokine-producing myeloid cell populations in Irf5 (-/-) mice but not impa
229 ely, these data reveal that tumor-associated myeloid cells provide signals critical for T-ALL growth
231 overed that deletion of TGFbeta signaling on myeloid cells (PyMT/TGFbetaRII(LysM)) affects extracellu
232 ine axis, which may orchestrate inflammatory myeloid cell recruitment and expression of damage mediat
236 recruitment to sites of injury or pathology, myeloid cells represent therapeutic targets for a broad
238 ic approaches aimed at resolving detrimental myeloid cell responses in tissues, including those occur
240 nt mice decreases the number of inflammatory myeloid cells, restores cortical dendritic spine dynamic
241 with this possibility, in vivo depletion of myeloid cells results in a significant reduction in leuk
242 ence in mice that lack Beclin 1 or FIP200 in myeloid cells results in spontaneous immune activation a
244 ompounds with known pharmacology using human myeloid cells, searching for those that enhance TREM2 pr
246 ic plasticity and convergence among distinct myeloid cells so that they may act as a functional unit
250 fies a previously unrecognized requisite for myeloid cell STAT3 in the activation of myelin-reactive
251 lncRNA LUCAT1 which is upregulated in human myeloid cells stimulated with lipopolysaccharide and oth
252 ne (soluble triggering receptor expressed on myeloid cells [sTREM-1], interleukin-6, interleukin-8, c
256 ate and adaptive immune responses that prime myeloid cells, such as macrophages, protect against path
257 Increased cellular ATP underpins increased myeloid cell superoxide production and phagocytosis asso
259 SCs, and its deletion transformed MDSCs into myeloid cells that activated CD8(+) T cell-mediated immu
260 ) are a heterogeneous population of immature myeloid cells that proliferate in the setting of cancer
262 ct populations of nerve-resident homeostatic myeloid cells that transcriptionally differed from centr
263 plications in the view of the growing use of myeloid cell therapies to treat brain disease in humans.
264 C formation, involving a direct contact with myeloid cells through CD40L-CD40 interaction and IFN-gam
266 Complementation of cytokines produced by myeloid cells to cocultures of LACC1-deficient myeloid c
267 These findings demonstrate the ability of myeloid cells to directly react to pathogenic T cell inf
268 10 from effector T cells signals to CD11c(+) myeloid cells to suppress an atypical and pathogenic IFN
272 itch of IL6 signaling from a canonical mode (myeloid cells) to a noncanonical trans-signaling mode (a
273 oro-crown ether payload ((19)F-HDL) to allow myeloid cell tracking by (19)F magnetic resonance imagin
277 supporting immunoregulatory polarization of myeloid cells upon infiltration into tumors remain large
278 tibodies or conditional depletion of Insr in myeloid cells using the Cre-loxP system protects mice fr
279 costimulatory signals from tumor-associated myeloid cells,v leading to enhanced TIL expansion and fu
282 y, selective abrogation of EGFR signaling in myeloid cells was sufficient to protect against nephriti
284 ion to IL-10's classic inhibitory effects on myeloid cells, we also describe the nonclassic roles att
291 of chronic autoimmune neuritis, homeostatic myeloid cells were outnumbered by infiltrating lymphocyt
293 AD risk genes are specifically expressed in myeloid cells, whereas others are ubiquitously expressed
294 roglia as well as newly recruited peripheral myeloid cells, which has implications for the role of my
295 taplegic homolog 7 (SMAD7) in CD34(+)PRLR(+) myeloid cells, which reduced the production of transform
296 L-1beta, and IL-6)-conditioning cytokines by myeloid cells, which then cross-regulated Th2 and regula
297 pply of bone marrow-derived brain-engrafting myeloid cells with donor wild-type CSF1R to repopulate t
298 evealed a wide heterogeneity of infiltrating myeloid cells with increased infiltration of PD-L1(+) TA
299 ng the migratory patterns of CP-infiltrating myeloid cells with intact and disrupted CX3CR1-CCR2 sign
300 tal cells, which are analogous to vertebrate myeloid cells, yet molecular underpinnings of the lymph